Tevogen Bio Holdings Inc. (TVGN)
NASDAQ: TVGN · Real-Time Price · USD
8.88
+0.93 (11.70%)
At close: May 18, 2026, 4:00 PM EDT
8.83
-0.05 (-0.56%)
Pre-market: May 19, 2026, 5:45 AM EDT
Tevogen Bio Holdings Employees
Tevogen Bio Holdings had 18 employees as of December 31, 2025. The number of employees did not change compared to the previous year.
Employees
18
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,219,032
Market Cap
37.19M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 18 | 0 | - |
| Dec 31, 2024 | 18 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Evaxion | 46 |
| Mereo BioPharma Group | 39 |
| Plus Therapeutics | 28 |
| Actinium Pharmaceuticals | 25 |
| INmune Bio | 21 |
| Veru Inc. | 20 |
| RenovoRx | 17 |
| Quantum BioPharma | 17 |
TVGN News
- 18 hours ago - Letter to Shareholders from CEO Dr. Ryan Saadi - GlobeNewsWire
- 6 days ago - Tevogen Bio Holdings Inc trading halted, volatility trading pause - TheFly
- 6 days ago - Tevogen Bio Holdings Inc trading resumes - TheFly
- 6 days ago - Tevogen Announces $3 Million Private Investment at $8 Per Share, a 14% Premium from Latest Market Close - GlobeNewsWire
- 21 days ago - Tevogen.AI Nears Completion of PredicTcell™ Training; Initiates Commercial Readiness and Debuts Internal Application Portal - GlobeNewsWire
- 7 weeks ago - Tevogen Advances Strategic CRO Evaluation to Expand Clinical Research Delivery Capabilities and Drive Revenue Growth - GlobeNewsWire
- 7 weeks ago - Tevogen regains compliance with Nasdaq minimum bid price requirement - TheFly
- 7 weeks ago - Tevogen Regains Compliance with Nasdaq Minimum Bid Price Requirement - GlobeNewsWire